Dinghai Zheng, Logan Persyn, Jun Wang, Yue Liu, Fernando Ulloa-Montoya, Can Cenik, Vikram Agarwal
{"title":"Predicting the translation efficiency of messenger RNA in mammalian cells","authors":"Dinghai Zheng, Logan Persyn, Jun Wang, Yue Liu, Fernando Ulloa-Montoya, Can Cenik, Vikram Agarwal","doi":"10.1038/s41587-025-02712-x","DOIUrl":null,"url":null,"abstract":"<p>The mechanisms by which mRNA sequences specify translational control remain poorly understood in mammalian cells. Here we generate a transcriptome-wide atlas of translation efficiency (TE) measurements encompassing more than 140 human and mouse cell types from 3,819 ribosomal profiling datasets. We develop RiboNN, a state-of-the-art multitask deep convolutional neural network, and classic machine learning models to predict TEs in hundreds of cell types from sequence-encoded mRNA features. While most earlier models solely considered the 5′ untranslated region (UTR) sequence, RiboNN integrates how the spatial positioning of low-level dinucleotide and trinucleotide features (that is, including codons) influences TE, capturing mechanistic principles such as how ribosomal processivity and tRNA abundance control translational output. RiboNN predicts the translational behavior of base-modified therapeutic RNA and explains evolutionary selection pressures in human 5′ UTRs. Finally, it detects a common language governing mRNA regulatory control and highlights the interconnectedness of mRNA translation, stability and localization in mammalian organisms.</p>","PeriodicalId":19084,"journal":{"name":"Nature biotechnology","volume":"93 1","pages":""},"PeriodicalIF":41.7000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1038/s41587-025-02712-x","RegionNum":1,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The mechanisms by which mRNA sequences specify translational control remain poorly understood in mammalian cells. Here we generate a transcriptome-wide atlas of translation efficiency (TE) measurements encompassing more than 140 human and mouse cell types from 3,819 ribosomal profiling datasets. We develop RiboNN, a state-of-the-art multitask deep convolutional neural network, and classic machine learning models to predict TEs in hundreds of cell types from sequence-encoded mRNA features. While most earlier models solely considered the 5′ untranslated region (UTR) sequence, RiboNN integrates how the spatial positioning of low-level dinucleotide and trinucleotide features (that is, including codons) influences TE, capturing mechanistic principles such as how ribosomal processivity and tRNA abundance control translational output. RiboNN predicts the translational behavior of base-modified therapeutic RNA and explains evolutionary selection pressures in human 5′ UTRs. Finally, it detects a common language governing mRNA regulatory control and highlights the interconnectedness of mRNA translation, stability and localization in mammalian organisms.
期刊介绍:
Nature Biotechnology is a monthly journal that focuses on the science and business of biotechnology. It covers a wide range of topics including technology/methodology advancements in the biological, biomedical, agricultural, and environmental sciences. The journal also explores the commercial, political, ethical, legal, and societal aspects of this research.
The journal serves researchers by providing peer-reviewed research papers in the field of biotechnology. It also serves the business community by delivering news about research developments. This approach ensures that both the scientific and business communities are well-informed and able to stay up-to-date on the latest advancements and opportunities in the field.
Some key areas of interest in which the journal actively seeks research papers include molecular engineering of nucleic acids and proteins, molecular therapy, large-scale biology, computational biology, regenerative medicine, imaging technology, analytical biotechnology, applied immunology, food and agricultural biotechnology, and environmental biotechnology.
In summary, Nature Biotechnology is a comprehensive journal that covers both the scientific and business aspects of biotechnology. It strives to provide researchers with valuable research papers and news while also delivering important scientific advancements to the business community.